rss
J Clin Pathol 2008;61:494-498 doi:10.1136/jcp.2007.052506
  • Original article

Expression of periostin in human breast cancer

  1. F Puglisi1,
  2. C Puppin2,
  3. E Pegolo3,
  4. C Andreetta1,
  5. G Pascoletti1,
  6. F D’Aurizio3,
  7. M Pandolfi3,
  8. G Fasola1,
  9. A Piga1,
  10. G Damante2,
  11. C Di Loreto3
  1. 1
    Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria di Udine, Italy
  2. 2
    Dipartimento di Scienze e Tecnologie Biomediche, Universitè di Udine, Italy
  3. 3
    Istituto di Anatomia Patologica Azienda Ospedaliero-Universitaria di Udine, Italy
  1. Professor Giuseppe Damante, Dipartimento di Scienze e Tecnologie Biomediche, Piazzale Kolbe 1, 33100 Udine, Italy; gdamante{at}mail.dstb.uniud.it
  • Accepted 1 October 2007
  • Published Online First 15 October 2007

Abstract

Background: Periostin is a secreted adhesion protein, normally expressed in mesenchime-derived cells. Aberrant expression of the periostin gene in epithelial tumours seems to play a role in angiogenesis and metastases.

Aims: To investigate periostin expression in a consecutive series of breast carcinomas and correlate it with established biological and prognostic factors.

Methods: A consecutive series of 206 breast carcinomas was investigated by immunohistochemistry with a specific antiperiostin antibody. Immunohistochemical expression of oestrogen and progesterone receptors, Ki-67 (MIB-1), HER-2/neu, VEGF-A, VEGFR-1 and VEGFR-2 was analysed. Periostin expression was also investigated in MCF-7 and MDA-468 cell lines by immunohistochemistry, western blot and quantitative RT-PCR. Localisation of periostin was investigated in MCF-7 cells by the green fluorescent protein (GFP) approach.

Results: Periostin was highly expressed in carcinoma cells, but not in normal breast tissues. The pattern of expression was mainly cytoplasmic. However, in 12% of cases a nuclear reactivity was observed. Nuclear periostin significantly correlated with tumour size, and with expression of oestrogen receptor, progesterone receptor, VEGF-A, VEGFR-1 and VEGFR-2. A nuclear localisation of periostin was also observed in MCF-7 and MDA-468 cell lines. In MCF-7 cells the nuclear localisation of periostin was also shown by transfection of a vector expressing a GFP-periostin chimeric protein.

Conclusions: Results indicate that the aberrant gene expression of periostin in breast cancer cells is associated with an abnormal nuclear localisation of the protein. The nuclear localisation of periostin in breast cancer may induce significant biological effects.

Footnotes

  • Competing interests: None.

  • Funding: This work is funded by grants from MIUR (PRIN no. 2005060778-002) and Regione Friuli Venezia Giulia to GD. CP is supported by the Fondazione Italiana Ricerca sul Cancro (FIRC) fellowship.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jcp.2007.052506v1
    2. 61/4/494 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar